The global creatine kinase reagent market, valued at approximately USD 296.2 million at the end of 2021, is poised for substantial growth, with projections indicating a compound annual growth rate ...
We expect Teradyne to maintain a strong balance sheet and continue generating robust free cash flow while keeping minimal to no leverage. As of Dec. 31, 2023, Teradyne held a net cash position, with ...